Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology

  title={Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology},
  author={Elaine Johanna Limkin and Roger Sun and Laurent Dercle and Evangelia I. Zacharaki and Charlotte Robert and Sylvain Reuz{\'e} and Antoine Schernberg and Nikos Paragios and Eric Deutsch and Charles Fert{\'e}},
  journal={Annals of Oncology},
Medical image processing and analysis (also known as Radiomics) is a rapidly growing discipline that maps digital medical images into quantitative data, with the end goal of generating imaging biomarkers as decision support tools for clinical practice. The use of imaging data from routine clinical work-up has tremendous potential in improving cancer care by heightening understanding of tumor biology and aiding in the implementation of precision medicine. As a noninvasive method of assessing the… 

Figures and Tables from this paper

The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges
The recent methodological developments in radiomics are reviewed, including data acquisition, tumor segmentation, feature extraction, and modelling, as well as the rapidly developing deep learning technology.
Radiomics in Nuclear Medicine Applied to Radiation Therapy: Methods, Pitfalls, and Challenges.
A review in radiomics: Making personalized medicine a reality via routine imaging
The present review aims to be a guidebook of sorts, describing the process of radiomics, its pitfalls, challenges, and opportunities, along with its ability to improve clinical decision‐making, from oncology and respiratory medicine to pharmacological and genotyping studies.
Radiomics and radiogenomics for precision radiotherapy
An overview of radiomics and radiogenomics is provided, including their rationale, technical and clinical aspects, and some examples of the current results and some emerging paradigms in radiomics for clinical oncology, with a focus on potential applications in radiotherapy.
Radiomics as Applied in Precision Medicine
Radiomics is the process of transferring the medical imaging interpretation knowledge and skill set from humans to machines in a way that they can see more, process more information, and have deeper insights into what the disease is and how it behaves and might respond to therapeutic intervention.
Radiomics in liver diseases: Current progress and future opportunities
  • Jingwei Wei, Hanyu Jiang, Jie Tian
  • Medicine, Biology
    Liver international : official journal of the International Association for the Study of the Liver
  • 2020
The methodological process in liver disease radiomics studies is reviewed in a stepwise fashion from data acquisition and curation, region of interest segmentation, liver‐specific feature extraction, to task‐oriented modelling, and the applications of radiomics in liver diseases are outlined.
From Medical Imaging to Radiomics: Role of Data Science for Advancing Precision Health
The main goal is implementing a protocol to quantify the image informative contents by first mining and then extracting the most representative features, and further analysis aims to detect potential disease phenotypes through signs and marks of heterogeneity.
Radiomics in cancer prognosis : applications and limitations of quantitative texture analysis
This thesis shows that histopathological differences in tumors can be observed using non-invasive diagnostic imaging through textural analysis, and is applicable to both CT and MRI and on different types of tumors.
Role of image-guided biopsy and radiomics in the age of precision medicine.
In the advancement towards that goal, image-guided biopsy can prove radiomic suspicions and conversely radiomics can guide image- guided biopsy to improve tissue yield, which will improve cancer understanding and patient outcomes.


Radiomics in glioblastoma: current status, challenges and potential opportunities
Improved statistical models are needed which relate GBM imaging features with patient outcomes with high specificity/sensitivity and more studies correlating radiomic features with disease outcomes and molecular attributes are also needed to illuminate the tumor biology.
Reproducibility of radiomics for deciphering tumor phenotype with imaging
Assessment of the reproducibility of a comprehensive, commonly-used set of radiomic features using a unique, same-day repeat computed tomography data set from lung cancer patients suggests that radiomic Features are reproducible over a wide range of imaging settings.
Radiomics: the process and the challenges.
Defining a Radiomic Response Phenotype: A Pilot Study using targeted therapy in NSCLC
This pilot study shows that radiomic data before treatment is able to predict mutation status and associated gefitinib response non-invasively, demonstrating the potential of radiomics-based phenotyping to improve the stratification and response assessment between tyrosine kinase inhibitors (TKIs) sensitive and resistant patient populations.
Deciphering Genomic Underpinnings of Quantitative MRI-based Radiomic Phenotypes of Invasive Breast Carcinoma
It is found that transcriptional activities of various genetic pathways were positively associated with tumor size, blurred tumor margin, and irregular tumor shape and that miRNA expressions were associated with the tumor size and enhancement texture, but not with other types of radiomic phenotypes.
Imaging biomarker roadmap for cancer studies
Experts assembled to review, debate and summarize the challenges of IB validation and qualification produced 14 key recommendations for accelerating the clinical translation of IBs, which highlight the role of parallel (rather than sequential) tracks of technical validation, biological/clinical validation and assessment of cost-effectiveness.
Radiomic Profiling of Glioblastoma: Identifying an Imaging Predictor of Patient Survival with Improved Performance over Established Clinical and Radiologic Risk Models.
An 11-feature radiomic signature that allows prediction of survival and stratification of patients with newly diagnosed glioblastoma was identified, and improved performance compared with that of established clinical and radiologic risk models was demonstrated.
Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome
This article discusses how analysis of intratumor heterogeneity can provide benefit over more simple biomarkers such as tumor size and average function and considers how imaging methods can be integrated with genomic and pathology data, instead of being developed in isolation.